Yu Hara

3.9k total citations
94 papers, 599 citations indexed

About

Yu Hara is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Yu Hara has authored 94 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pulmonary and Respiratory Medicine, 25 papers in Epidemiology and 18 papers in Physiology. Recurrent topics in Yu Hara's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Lung Cancer Treatments and Mutations (18 papers). Yu Hara is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Lung Cancer Treatments and Mutations (18 papers). Yu Hara collaborates with scholars based in Japan, United States and China. Yu Hara's co-authors include Takeshi Kaneko, Nobuaki Kobayashi, Nobuyuki Horita, Akihiko Kawana, Masaharu Shinkai, Hao Chen, Keisuke Watanabe, Kota Murohashi, Yusuke Saigusa and Soichiro Kanoh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yu Hara

85 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Hara Japan	13	315	158	110	103	76	94	599
David Zhang United States	12	292 0.9×	95 0.6×	85 0.8×	50 0.5×	83 1.1×	30	567
Stephan Eggeling Germany	14	414 1.3×	98 0.6×	97 0.9×	71 0.7×	38 0.5×	36	630
Yoshihiro Ohkuni Japan	12	163 0.5×	206 1.3×	63 0.6×	104 1.0×	102 1.3×	41	465
Norihiro Kaneko Japan	12	256 0.8×	210 1.3×	126 1.1×	169 1.6×	65 0.9×	57	698
Kristine E. Konopka United States	10	409 1.3×	73 0.5×	92 0.8×	99 1.0×	207 2.7×	23	692
Takefumi Saito Japan	14	416 1.3×	241 1.5×	56 0.5×	128 1.2×	168 2.2×	84	743
Sara Aquino Italy	13	338 1.1×	131 0.8×	76 0.7×	74 0.7×	133 1.8×	25	663
Arzu Balkan Türkiye	9	406 1.3×	62 0.4×	45 0.4×	55 0.5×	37 0.5×	26	548
Hideaki Yamakawa Japan	16	561 1.8×	281 1.8×	49 0.4×	46 0.4×	63 0.8×	90	787

Countries citing papers authored by Yu Hara

Since Specialization

Citations

This map shows the geographic impact of Yu Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Hara more than expected).

Fields of papers citing papers by Yu Hara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Hara. The network helps show where Yu Hara may publish in the future.

Co-authorship network of co-authors of Yu Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Hara. A scholar is included among the top collaborators of Yu Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Hara. Yu Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamamoto, Shota, Nobuyuki Horita, Johsuke Hara, et al.. (2024). Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough. CHEST Journal. 166(5). 1124–1140. 4 indexed citations

Tanabe, Naoya, Yu Hara, Kaoruko Shimizu, et al.. (2024). A protocol for a Japanese prospective cohort evaluating the features of patients with uncontrolled asthma achieving clinical remission: J-CIRCLE. Respiratory Investigation. 62(6). 1209–1214. 1 indexed citations

Kobayashi, Nobuaki, et al.. (2023). Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patients. Journal of Infection and Chemotherapy. 30(1). 48–52. 2 indexed citations

Yamamoto, Masaki, Ken Tashiro, Yu Hara, et al.. (2023). Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non‐small cell lung carcinoma. Thoracic Cancer. 14(25). 2601–2607. 2 indexed citations

Horita, Nobuyuki, Megumi Kaneko, Kota Murohashi, et al.. (2023). Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology. 15. 2643189–2643189. 3 indexed citations

Koya, Toshiyuki, Kazuhisa Asai, Takashi Iwanaga, et al.. (2023). Characterization of Severe Uncontrolled Asthma in Japan: Analysis of Baseline Data from the PROSPECT Study. Journal of Asthma and Allergy. Volume 16. 597–609. 1 indexed citations

Hara, Yu, Yusuke Saigusa, Kota Murohashi, et al.. (2023). ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease. Canadian Respiratory Journal. 2023. 1–10. 7 indexed citations

Chen, Hao, Nobuyuki Horita, Ho Namkoong, et al.. (2022). Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy. Therapeutic Advances in Medical Oncology. 14. 4277477184–4277477184.

Hara, Yu, Kota Murohashi, Ryo Nagasawa, et al.. (2021). Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases. Canadian Respiratory Journal. 2021. 1–9. 4 indexed citations

10.

Kobayashi, Nobuaki, Keisuke Watanabe, Nobuyuki Horita, et al.. (2021). T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer. Thoracic Cancer. 12(11). 1726–1734. 5 indexed citations

11.

Kobayashi, Nobuaki, et al.. (2021). Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis. Thoracic Cancer. 12(7). 1096–1105. 13 indexed citations

12.

Kobayashi, Nobuaki, Keisuke Watanabe, Nobuyuki Horita, et al.. (2021). Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study. Thoracic Cancer. 12(23). 3281–3285. 1 indexed citations

13.

Horita, Nobuyuki, Ho Namkoong, Keisuke Watanabe, et al.. (2021). Best regimens for treating chemo‐naïve incurable squamous non‐small cell lung cancer with a programmed death‐ligand 1 tumor proportion score of 1%–49%: A network meta‐analysis. Thoracic Cancer. 13(1). 84–94. 3 indexed citations

14.

Hara, Yu, Ryo Nagasawa, Kota Murohashi, et al.. (2021). The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease. Canadian Respiratory Journal. 2021. 1–8. 1 indexed citations

15.

Kobayashi, Nobuaki, Keisuke Watanabe, Nobuyuki Horita, et al.. (2021). Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial. Thoracic Cancer. 13(2). 228–235. 11 indexed citations

16.

Chen, Honglei, et al.. (2020). Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors. SHILAP Revista de lepidopterología.

17.

Hara, Yu, Koji Okudela, Yoshihiro Ishikawa, et al.. (2020). Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax. Thoracic Cancer. 11(11). 3407–3408. 2 indexed citations

18.

Chen, Hao, Nobuyuki Horita, Kentaro Ito, et al.. (2020). Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis. Therapeutic Advances in Medical Oncology. 12. 3863580881–3863580881. 7 indexed citations

19.

Kobayashi, Nobuaki, Hisashi Hashimoto, Kentaro Nakashima, et al.. (2020). Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan. Tuberculosis. 125. 101992–101992. 12 indexed citations

20.

Kobayashi, Nobuaki, Hisashi Hashimoto, Kentaro Nakashima, et al.. (2020). MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer. Thoracic Cancer. 11(10). 2975–2982. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact